Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
platinum chemotherapy
DRUG
2 trials
Sponsors
Chinese PLA General Hospital
, Assistance Publique - Hôpitaux de Paris
Conditions
Neuroendocrine Tumors
Ovarian Cancer
Phase 2
A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer
Completed
NCT03989336
Chinese PLA General Hospital
Ovarian Cancer
Start: 2020-12-23
End: 2023-12-10
Updated: 2024-07-15
Unknown Phase
Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors
Completed
NCT04365023
Assistance Publique - Hôpitaux de Paris
Neuroendocrine Tumors
Start: 2020-07-02
End: 2023-05-25
Updated: 2026-02-13
Related Papers
Combined regimen of inhalable STING agonist plus chemoimmunotherapy in platinum-resistant or platinum-refratory ovarian cancer: A randomized, open-label, phase II trial.
Journal of Clinical Oncology
2020-05-20
1 citations